Patent Assignment
Reel/Frame 065175/0215
Assignment of Assignor's Interest
Recorded: 2023-10-10
Pages: 3
Assignor
TILLOTTS PHARMA AG
Executed: 2017-01-06
Assignee
CANCER PREVENTION PHARMACEUTICALS, INC.
712 VISTA BLVD., #305, WACONIA, MINNESOTA, 55387
Covered Property
(1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 10, 2023
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 065174/0989 →
Assignment of Assignor's Interest
Oct 10, 2023
From: BRAVO GONZALEZ, ROBERTO CARLOS
To: TILLOTTS PHARMA AG
Reel/Frame 065175/0044 →
Assignment of Assignor's Interest
Oct 10, 2023
From: SHANNON, PATRICK
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 065175/0107 →
Assignment of Assignor's Interest
Oct 10, 2023
From: SANOFI WINTHROP INDUSTRIE S.A.
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 065175/0153 →
Assignment of Assignor's Interest
Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest
Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →